Cargando…
Repurposing existing drugs for cardiovascular risk management: a focus on methotrexate
About 20% of patients with a history of atherosclerotic cardiovascular disease will experience further cardiovascular events despite maximal pharmacological treatment with cardioprotective drugs. This highlights the presence of residual cardiovascular risk in a significant proportion of patients and...
Autores principales: | Mangoni, Arduino A, Tommasi, Sara, Zinellu, Angelo, Sotgia, Salvatore, Carru, Ciriaco, Piga, Matteo, Erre, Gian Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioExcel Publishing Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6239018/ https://www.ncbi.nlm.nih.gov/pubmed/30459819 http://dx.doi.org/10.7573/dic.212557 |
Ejemplares similares
-
Protective Effects of Methotrexate against Proatherosclerotic Cytokines: A Review of the Evidence
por: Mangoni, Arduino A., et al.
Publicado: (2017) -
A Capillary Electrophoresis-Based Method for the Measurement of Hydroxychloroquine and Its Active Metabolite Desethyl Hydroxychloroquine in Whole Blood in Patients with Rheumatoid Arthritis
por: Sotgia, Salvatore, et al.
Publicado: (2022) -
B-Type Natriuretic Peptide Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression
por: Zinellu, Angelo, et al.
Publicado: (2021) -
Oxidative Stress Biomarkers and Peripheral Endothelial Dysfunction in Rheumatoid Arthritis: A Monocentric Cross-Sectional Case-Control Study
por: Bassu, Stefania, et al.
Publicado: (2020) -
Strategies to enhance graphic and results interpretation of a regression-based approach for method comparison studies
por: Sotgia, Salvatore, et al.
Publicado: (2017)